Research Solutions, Inc. (RSSS) director granted options for 50,000 shares

Rhea-AI Filing Summary

A director of Research Solutions, Inc. reported receiving an option to purchase 50,000 shares of the company’s common stock. The stock option was granted on 11/12/2025 with an exercise price of $3.07 per share and an expiration date of 11/11/2035. The option was reported as directly owned and carried a price of $0 at grant, indicating it was an award rather than a market purchase.

According to the vesting terms, one-third of the options vest on November 12, 2026, and one-twelfth of the options vest on the last day of each quarter beginning December 31, 2026 until fully vested. This creates a multi‑year vesting schedule that ties the director’s potential ownership to ongoing service and future company performance.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gayron Kenneth L

(Last) (First) (Middle)

C/O RESEARCH SOLUTIONS, INC.

(Street)

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Research Solutions, Inc. [ RSSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase common stock	$3.07	11/12/2025		A		50,000		(1)	11/11/2035	Common Stock	50,000	$0	50,000	D

Explanation of Responses:

1. 1/3rd of the options vest on November 12, 2026 and 1/12th of the options vest on the last day of each quarter beginning December 31, 2026 until fully vested.

	/s/ David Kutil, Attorney-in-Fact	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Research Solutions (RSSS) report in this Form 4?

The filing reports that a director of Research Solutions, Inc. received an option to purchase 50,000 shares of common stock.

What are the key terms of the stock options granted by Research Solutions (RSSS)?

The director received an option for 50,000 shares of common stock at an exercise price of $3.07 per share, granted on 11/12/2025 and expiring on 11/11/2035.

How do the Research Solutions (RSSS) director stock options vest?

One-third of the options vest on November 12, 2026, and one-twelfth vests on the last day of each quarter starting December 31, 2026 until fully vested.

Is the Research Solutions (RSSS) director’s option award a direct holding?

Yes. The 50,000 stock options are reported as direct ownership by the director.

Did the Research Solutions (RSSS) director pay anything at the time of the option grant?

No cash price was paid at grant; the price of the derivative security is reported as $0, consistent with an equity award.